CVS
CVS Health Corp
$
62.470
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
62.700
Open
62.320
VWAP
62.24
Vol
11.37M
Mkt Cap
79.03B
Low
61.190
Amount
707.99M
EV/EBITDA(TTM)
8.04
Total Shares
1.26B
EV
130.79B
EV/OCF(TTM)
14.96
P/S(TTM)
0.21
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
96.76B
+2.3%
2.284
+1.5%
100.70B
+3.06%
0.967
-18.78%
97.46B
+2.13%
1.434
+31.59%
Estimates Revision
The market is revising Downward the revenue expectations for CVS Health Corporation (CVS) for FY2025, with the revenue forecasts being adjusted by -0.61% over the past three months. During the same period, the stock price has changed by -10.05%.
Revenue Estimates for FY2025
Revise Downward
-0.61%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+3.72%
In Past 3 Month
Stock Price
Go Down
-10.05%
In Past 3 Month
16 Analyst Rating
29.45% Upside
Wall Street analysts forecast CVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVS is 80.87 USD with a low forecast of 71.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Buy
2 Hold
0 Sell
Strong Buy
29.45% Upside
Current: 62.470
Low
71.00
Averages
80.87
High
95.00
29.45% Upside
Current: 62.470
Low
71.00
Averages
80.87
High
95.00
UBS
Neutral
downgrade
$71 -> $67
2025-07-22
Reason
UBS
Price Target
$71 -> $67
2025-07-22
downgrade
Neutral
Reason
UBS lowered the firm's price target on CVS Health to $67 from $71 and keeps a Neutral rating on the shares. UBS says the firm is tempering its expectations for Q2, and feels that the reiteration of guidance is "good enough," the analyst tells investors in a research note.
Morgan Stanley
Overweight
maintain
$80
2025-07-10
Reason
Morgan Stanley
Price Target
$80
2025-07-10
maintain
Overweight
Reason
Morgan Stanley views CVS's path to Medicare Advantage margin recovery as underappreciated, though risks remain, the analyst tells investors in a research note. The firm, which has an Overweight rating and $80 price target on CVS shares, thinks CVS could have the "cleanest" Q2 and should be favorably positioned in light of competitive dynamics.
Jefferies
Brian Tanquilut
maintain
$74 -> $80
2025-06-30
Reason
Jefferies
Brian Tanquilut
Price Target
$74 -> $80
2025-06-30
maintain
Reason
Jefferies analyst Brian Tanquilut raised the firm's price target on CVS Health to $80 from $74 and keeps a Buy rating on the shares. CVS is one of the firm's large-cap picks, with Jefferies telling investors in a research note that management has been prudently conservative with guidance, leaving room for EPS upside despite well-digested secular headwinds in Medicare Advantage.
Barclays
Andrew Mok
Overweight
downgrade
$82 -> $79
2025-06-02
Reason
Barclays
Andrew Mok
Price Target
$82 -> $79
2025-06-02
downgrade
Overweight
Reason
Barclays analyst Andrew Mok lowered the firm's price target on CVS Health to $79 from $82 and keeps an Overweight rating on the shares. Following Q1 earnings and "several negative data points" around Part D mix, Affordable Care Act trend, and preliminary 2026 ACA rates, the firm is more concerned on the Medicare Part D and individual ACA businesses, which it believes carry negative earnings risk for the balance of 2025 and face significant premium increases and disruption in 2026. With limited prospects of multiple expansion and an unfavorable managed care catalyst calendar, investors are likely to be more sensitive to earnings revisions, which skew negatively for Part D- and ACA-sensitive stocks, the analyst tells investors in a research note. Barclays continues to prefer hospitals to managed care.
RBC Capital
Ben Hendrix
Outperform
maintain
$525
2025-05-13
Reason
RBC Capital
Ben Hendrix
Price Target
$525
2025-05-13
maintain
Outperform
Reason
RBC Capital analyst Ben Hendrix is maintaining an Outperform rating and $525 price target on UnitedHealth (UNH) shares amid intra-day weakness, telling investors that the firm believes Tuesday's move prices in nearly 200 basis points of incremental Medicare Advantage margin deterioration, which RBC believes is "adequate to call a bottom on shares." While UnitedHealth is still trying to get a handle on trend amid a leadership transition, the firm still sees less of a ramp back to target margin versus MA peers Humana (HUM) and CVS Health (CVS), says the analyst, adding that the firm is "encouraged" by board chairman and former CEO Stephen Hemsley's return to the helm upon Andrew Witty's departure.
Truist
NULL -> Buy
maintain
$82 -> $84
2025-05-12
Reason
Truist
Price Target
$82 -> $84
2025-05-12
maintain
NULL -> Buy
Reason
Truist raised the firm's price target on CVS Health to $84 from $82 and keeps a Buy rating on the shares as part of a broader research note on Health Care Services. The firm is updating its models to reflect Q1 results and updated guidance on select names, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for CVS Health Corp (CVS.N) is 10.07, compared to its 5-year average forward P/E of 10.05. For a more detailed relative valuation and DCF analysis to assess CVS Health Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
10.05
Current PE
10.07
Overvalued PE
11.44
Undervalued PE
8.65
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
9.06
Current EV/EBITDA
9.09
Overvalued EV/EBITDA
9.92
Undervalued EV/EBITDA
8.20
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
0.30
Current PS
0.20
Overvalued PS
0.39
Undervalued PS
0.22
Financials
Annual
Quarterly
FY2025Q1
YoY :
+6.96%
94.59B
Total Revenue
FY2025Q1
YoY :
+66.97%
4.06B
Operating Profit
FY2025Q1
YoY :
+58.54%
1.78B
Net Income after Tax
FY2025Q1
YoY :
+60.23%
1.41
EPS - Diluted
FY2025Q2
YoY :
-47.37%
1.29B
Free Cash Flow
FY2025Q2
YoY :
-100.00%
N/A
Gross Profit Margin - %
FY2025Q2
YoY :
-14.48%
1.24
FCF Margin - %
FY2025Q2
YoY :
-100.00%
N/A
Net Margin - %
FY2025Q2
YoY :
-0.60%
6.64
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
254.2M
USD
4
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
100.0K
USD
Months
3-6
0
0.0
USD
Months
6-9
1
2.0M
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
3.8M
Volume
1
3-6
Months
2.5M
Volume
8
6-9
Months
4.7M
Volume
11
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
11
6.0M
Volume
Months
6-9
10
7.8M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress areSelling! The selling amount has increased171.32%over the last month.
Sold
0-3
Months
175.0K
USD
1
3-6
Months
255.5K
USD
8
6-9
Months
81.0K
USD
4
0-12
Months
16.0K
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
4
199.0K
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
254.2M
USD
4
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
100.0K
USD
Months
3-6
0
0.0
USD
Months
6-9
1
2.0M
USD
Months
0-12
0
0.0
USD
Months
CVS News & Events
Events Timeline
2025-07-31 (ET)
2025-07-31
08:27:05
CVS Health says confident in adequacy of reserves
2025-07-31
08:13:56
CVS Health says 'clear opportunities' for outperformance in FY25
2025-07-31
07:57:44
CVS Health raises FY25 revenue to 'at least' $391.5B from 'at least' $382.6B
Sign Up For More Events
Sign Up For More Events
News
9.5
07-31BenzingaPinnedCVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
9.5
07-31TipRanksPinnedCVS Earnings: CVS Health Stock Pops on Q2 Beat and Upgraded Outlook
9.5
07-31CNBCPinnedCVS shares pop on earnings beat and outlook, as retail pharmacy and insurance units improve
Sign Up For More News
People Also Watch
BNGO
Bionano Genomics Inc
2.950
USD
-1.99%
FUN
Six Flags Entertainment Corp
29.690
USD
-0.90%
DELL
Dell Technologies Inc
127.320
USD
-4.05%
PPC
Pilgrims Pride Corp
47.930
USD
+1.14%
GAME
GameSquare Holdings Inc
0.811
USD
-5.48%
EXP
Eagle Materials Inc
220.440
USD
-1.72%
SNT
Senstar Technologies Corp
4.270
USD
-2.51%
MCO
Moody's Corp
501.280
USD
-2.80%
PAY
Paymentus Holdings Inc
28.290
USD
+1.47%
AMP
Ameriprise Financial Inc
501.520
USD
-3.22%
FAQ
What is CVS Health Corp (CVS) stock price today?
The current price of CVS is 62.47 USD — it has increased 0.6 % in the last trading day.
What is CVS Health Corp (CVS)'s business?
What is the price predicton of CVS Stock?
What is CVS Health Corp (CVS)'s revenue for the last quarter?
What is CVS Health Corp (CVS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for CVS Health Corp (CVS)'s fundamentals?
How many employees does CVS Health Corp (CVS). have?